Delivery Order SPE2DB22D2218-SPE2DB24FR2FA

Award Date 3/21/24
Potential Completion Date 4/11/24
Potential Value $4.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and the pharmaceutical distributor Amerisourcebergen Drug Corp. The $8,937.84 firm fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $53,627.04 Firm Fixed Price Delivery Order contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of August 5, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $5,958.56, is for the delivery of RYANODEX 250 MG VIALS, a specialty pharmaceutical product, to support military treatment programs and facilities. No set-aside designation was used for this award....
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Medical Supply Chain division of the Defense agency. The award, valued at $4,468.92, was issued to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of June 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The $2,979.28 firm-fixed-price contract has a completion date of July 11, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,489.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product, with a completion date of November 29, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing arrangement. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,816.32, is a delivery order for 4567143430 RYANODEX 250 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $3,210.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYANODEX 250 MG VIALS, a medical product. The contract has a completion date of March 26, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.44 firm-fixed-price delivery order is for the supply of RYANODEX 250MG VIAL 1S, a medical product, with a period of performance ending on January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,632.64 and is a Firm Fixed Price Delivery Order for the supply of RYANODEX 250 MG VIALS. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB24FR2FA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,468.92 firm fixed price delivery order is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of April 11, 2024.

Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award is a delivery order issued under that IDC. No set-aside designation was used for this contract.

Generated 6/20/24, 9:29 AM